✦ LIBER ✦

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

✍ Scribed by J. Horti; E. Juhasz; Z. Monostori; K. Maeda; S. Eckhardt; I. Bodrogi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of TZT-1027, a novel synth

✍ Nobuyuki Yamamoto; Masahiro Andoh; Masaaki Kawahara; Masahiro Fukuoka; Hisanobu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

A phase 2 study of TZT-1027, administere

✍ Riely, Gregory J.; Gadgeel, Shirish; Rothman, Ivan; Saidman, Bruce; Sabbath, Ker 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase I study of TZT-1027, a novel synth

✍ Kenji Tamura; Kazuhiko Nakagawa; Takayasu Kurata; Taroh Satoh; Toshiji Nogami; K 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 342 KB

A phase I study of dexosome immunotherap

✍ Michael A Morse; Jennifer Garst; Takuya Osada; Shubi Khan; Amy Hobeika; Timothy 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 229 KB

Phase I and pharmacologic study of BNP77

✍ Noriyuki Masuda; Shunichi Negoro; Frederick Hausheer; Kazuhiko Nakagawa; Kaoru M 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 532 KB

A phase I/II study of pemetrexed and vin

✍ Clarke, Stephen J.; Boyer, Michael J.; Millward, Michael; Underhill, Craig; Moyl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB